Thomas, McNerney &a; Partners
Thomas, McNerney &a; Partners is a health care venture capital firm with approximately $600 million under management focused on investing in
Business Model:
Revenue: $14.3M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Thomas, McNerney &a; Partners Information
Geographic Data
Address: 263 Tresser Blvd 9th Floor
City: Stamford
State: CT
Zip: 06901
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Thomas, McNerney &a; Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest. Thomas, McNerney &a; Partners invests in companies at all stages of their development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. The partnership also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations.
Contact Phone:
+12039782010
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2003 | OsteoBiologics | Venture Round | 9.2M |
| 8/2007 | Leptos Biomedical | Series C | 20M |
| 2/2011 | VertiFlex | Venture Round | 14M |
| 12/2006 | Galil Medical | Venture Round | 52M |
| 6/2011 | CAS Medical Systems | Post-IPO Equity | 15M |
| 12/2006 | Elron Ventures | Post-IPO Equity | 52M |
| 7/2016 | Torax Medical | Series E | 0 |
| 1/2013 | AxioMed Spine | Series D | 0 |
| 3/2009 | Atritech | Venture Round | 0 |
| 11/2012 | Auspex Pharmaceuticals | Series D | 0 |
| 9/2014 | SG Biofuels | Series C | 11M |
| 1/2012 | SG Biofuels | Series B | 17M |
| 4/2009 | Torax Medical | Series C | 15M |
| 6/2005 | Torax Medical | Series B | 10M |
| 7/2005 | Solstice Neurosciences | Venture Round | 8M |
| 8/2006 | Zogenix | Series A | 60M |
| 9/2010 | Celator Pharmaceuticals | Series D | 0 |
| 7/2006 | Ocera Therapeutics | Series B | 12M |
| 2/2005 | AxioMed Spine | Series B | 18M |
| 10/2010 | AxioMed Spine | Series D | 0 |
| 9/2010 | Cebix | Venture Round | 16M |
| 10/2012 | Cebix | Series B | 0 |
| 10/2010 | Auspex Pharmaceuticals | Series C | 12M |
| 1/2014 | Auspex Pharmaceuticals | Series E | 0 |
| 11/2006 | Solstice Neurosciences | Series B | 85M |
| 11/2007 | Clarus Therapeutics | Series C | 8M |
| 11/2009 | Virdante Pharmaceuticals | Series A | 30M |
| 1/2010 | Intuity Medical | Series D | 64M |
| 1/2004 | Intuity Medical | Series B | 0 |
| 9/2004 | Coley Pharmaceutical Group | Series G | 25.2M |
| 10/2014 | Invitae | Series F | 0 |
| 5/2010 | Ntprx | Series B | 43M |
| 9/2012 | Torax Medical | Series D | 0 |
| 3/2017 | VertiFlex | Equity | 45.3M |
| 12/2011 | InnoPharma | Series A | 15M |
| 5/2005 | Tranzyme | Series A | - |
| 11/2006 | Quinnova Pharmaceuticals | Series A | 13.6M |
| 8/2006 | Intuity Medical | Series C | 20M |
| 7/2010 | Zogenix | Venture Round | 0 |
| 10/2009 | Quinnova Pharmaceuticals | Series B | 17.4M |
| 3/2006 | Clarus Therapeutics | Series B | - |
| 12/2006 | Softscope Medical Technologies | Series A | 4M |
| 8/2003 | Coley Pharmaceutical Group | Series F | 30M |
| 2/2008 | Ocera Therapeutics | Series C | 0 |
| 11/2007 | Tranzyme | Venture Round | 20M |
| 4/2012 | Tioga Pharmaceuticals | Series B | 10M |
| 2/2010 | Altair Therapeutics | Series B | 17M |
| 2/2004 | Clarus Therapeutics | Series A | 2.5M |
| 3/2017 | VertiFlex | Venture Round | 0 |
| 7/2016 | Torax Medical | Series E | 0 |
| 10/2014 | Invitae | Series F | 0 |
| 9/2014 | SG Biofuels | Series C | 0 |
| 1/2014 | Auspex Pharmaceuticals | Series E | 0 |
| 1/2013 | AxioMed Spine | Series D | 0 |
| 11/2012 | Auspex Pharmaceuticals | Series D | 0 |
| 10/2012 | Cebix | Series B | 0 |
| 9/2012 | Torax Medical | Series D | 0 |
| 4/2012 | Tioga Pharmaceuticals | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
